Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,173 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
A struggling medtech name is sparking renewed optimism from analysts. This guide breaks down why a 65% upside is poss...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
Thinking about turning a solid investment into a multi-bagger? This guide outlines five stock ideas with the potentia...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
A family facing a life-or-death medical flight denied by a major insurer turns to social media and billionaire Mark C...
AI chatbots are increasingly used for mental health information, but safety gaps threaten personal finances as insure...